4-8592901-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001014447.3(CPZ):āc.68A>Gā(p.Glu23Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000912 in 1,534,506 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001014447.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPZ | NM_001014447.3 | c.68A>G | p.Glu23Gly | missense_variant | 1/11 | ENST00000360986.9 | NP_001014447.2 | |
CPZ | NM_003652.4 | c.68A>G | p.Glu23Gly | missense_variant | 1/10 | NP_003643.3 | ||
CPZ | NM_001014448.3 | c.-607A>G | 5_prime_UTR_variant | 1/11 | NP_001014448.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPZ | ENST00000360986.9 | c.68A>G | p.Glu23Gly | missense_variant | 1/11 | 1 | NM_001014447.3 | ENSP00000354255.4 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151998Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000316 AC: 4AN: 126744Hom.: 0 AF XY: 0.0000574 AC XY: 4AN XY: 69654
GnomAD4 exome AF: 0.00000940 AC: 13AN: 1382508Hom.: 0 Cov.: 35 AF XY: 0.0000132 AC XY: 9AN XY: 682400
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151998Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 74218
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2023 | The c.68A>G (p.E23G) alteration is located in exon 1 (coding exon 1) of the CPZ gene. This alteration results from a A to G substitution at nucleotide position 68, causing the glutamic acid (E) at amino acid position 23 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at